JPH035470A - Production of optically active gamma-lactone derivative - Google Patents

Production of optically active gamma-lactone derivative

Info

Publication number
JPH035470A
JPH035470A JP1140799A JP14079989A JPH035470A JP H035470 A JPH035470 A JP H035470A JP 1140799 A JP1140799 A JP 1140799A JP 14079989 A JP14079989 A JP 14079989A JP H035470 A JPH035470 A JP H035470A
Authority
JP
Japan
Prior art keywords
group
general formula
optically active
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1140799A
Other languages
Japanese (ja)
Other versions
JPH0631201B2 (en
Inventor
Takashi Takahashi
孝志 高橋
Kiwa Takehira
竹平 喜和
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Osaka Soda Co Ltd
Original Assignee
Daiso Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiso Co Ltd filed Critical Daiso Co Ltd
Priority to JP1140799A priority Critical patent/JPH0631201B2/en
Publication of JPH035470A publication Critical patent/JPH035470A/en
Publication of JPH0631201B2 publication Critical patent/JPH0631201B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Furan Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

PURPOSE:To easily obtain the subject compound useful as a synthetic intermediate for prostaglandin, in high efficiency at a low cost, by carrying out intramolecular cyclization of a specific optically active compound in the presence of an acid catalyst. CONSTITUTION:An optically active compound of formula I [R<1> is (alkoxy)alkyl, cycloalkyl or 1-12C group of aralkyl having hetero atom on aromatic group or alkyl group; R<2> is H or easily eliminable protecting group of acyl, silyl, aralkyl or alkyloxyalkyl; R<4> is 1-5C lower alkyl; C labeled with * is asymmetric C] is hydrolyzed in a solvent consisting of water and methanol, etc., in the presence of an acid catalyst (e.g. CuSO4) at room temperature to 80 deg.C to effect the intramolecular lactonization and obtain the objective compound of formula V having an optical activity of (3S, 3'S, 4S), etc., and useful as a synthetic intermediate for PGF of formula II or PGE of formula III {in the case of natural prostaglandin, R<1> is n-C5H11; R<2> is [(CH2)6COOH or group of formula IV]}.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は、G、 5torkらによって開発されたプロ
スタグランジン合成法(G、5tork、  T、Ta
kahashi。
Detailed Description of the Invention (Field of Industrial Application) The present invention is based on a prostaglandin synthesis method (G, 5tork, T, Ta
kahashi.

1、Kawamoto、 T、5uzuki : J、
Am、Chem、Soc、、 100 。
1. Kawamoto, T., 5uzuki: J.
Am, Chem, Soc,, 100.

8272 (1978) )における重要な中間体であ
る、下記一般式(P) (上記一般式(P)において、R1はアルコキシ基を有
していてもよいアルキル基、シクロアルキル基及び芳香
環もしくはアルキル基にヘテロ原子を有するアラルキル
基から選ばれた炭素数1〜12の基、R2は水素原子又
はアシル基、シリル基、アラルキル基及びアルキルオキ
シアルキル基から選ばれた容易に間離可能な保護基を表
わし、*の符号は不斉炭素原子を表わす)で表わされる
光学活性γ−ラクトン誘導体の製法に関する。
8272 (1978)) is an important intermediate in the following general formula (P) (In the above general formula (P), R1 is an alkyl group that may have an alkoxy group, a cycloalkyl group, an aromatic ring, or an alkyl group. A group having 1 to 12 carbon atoms selected from aralkyl groups having a heteroatom in the group, R2 is a hydrogen atom or an easily separable protecting group selected from acyl groups, silyl groups, aralkyl groups, and alkyloxyalkyl groups. and the symbol * represents an asymmetric carbon atom).

(従来の技術及び解決すべき課題) プロスタグランジンの製造に関しては、上記G、 5t
orkらの合成法の他に、コーリーラクトンや4−ヒド
ロキシシクロベンテノンより出発する方法が実用化され
ているが、この方法はtU4の光学活性体を得るために
光学分割や微生物による不斉水解などの工程を経る必要
があり、さらにこれらを基にしてα、ω側鎖を導入して
いく段階での立体制御においても問題点が多い。このよ
うな点からみると上記G、 5torkらにより開発さ
れた前記一般式(P)の光学活性γ−ラクトン誘導体を
鍵中間体とするプロスタグランジン合成法は優れた方法
であるといえる。しかしながら、この方法における問題
点は鍵中間体となる一般式(P)の化合物をいかに経済
的に製造できるかにかかつていた。
(Prior art and problems to be solved) Regarding the production of prostaglandin, the above G, 5t
In addition to the synthetic method of Ork et al., a method starting from Corey lactone or 4-hydroxycyclobentenone has been put into practical use, but this method requires optical resolution or asymmetric hydrolysis by microorganisms to obtain an optically active form of tU4. It is necessary to go through the following steps, and there are also many problems in the stereoscopic control at the stage of introducing α and ω side chains based on these steps. From this point of view, the prostaglandin synthesis method using the optically active γ-lactone derivative of general formula (P) as a key intermediate, developed by G. 5tork et al., can be said to be an excellent method. However, the problem with this method lies in how economically the compound of general formula (P), which serves as a key intermediate, can be produced.

(課題を解決するための手段) 本発明者らは、上記問題点を解決すべく鋭意検討の結果
、鍵中間体である本発明の上記一般式(P)で表わされ
る化合物を従来より簡便に、且つ効率よく製造する方法
を見出したものである。
(Means for Solving the Problems) As a result of intensive studies to solve the above problems, the present inventors have found that the compound represented by the above general formula (P) of the present invention, which is a key intermediate, can be produced more easily than before. , and found a method for manufacturing it efficiently.

本発明は、下記一般式(B) R4は炭素数1〜5の低級アルキル基を表わし、*の符
号は不斉炭素原子を表わす) で表わされる光学活性化合物を酸触媒の存在下で分子内
閉環させることを特徴とする下記一般式(P)で表わさ
れる光学活性γ−ラクトン誘導体の製法である。
In the present invention, an optically active compound represented by the following general formula (B) (R4 represents a lower alkyl group having 1 to 5 carbon atoms, and the symbol * represents an asymmetric carbon atom) is synthesized within the molecule in the presence of an acid catalyst. This is a method for producing an optically active γ-lactone derivative represented by the following general formula (P), which is characterized by ring closure.

(上記一般式(B)において、R1はアルコキシ基を有
していてもよいアルキル基、シクロアルキル基及び芳香
環もしくはアルキル基にヘテロ原子を有するアラルキル
基から選ばれた炭素数1〜12の基、R2は水素原子又
はアシル基、シリル基、アラルキル基及びアルキルオキ
シアルキル基から選ばれた容易に脱離可能な保護基、上
記一般式(P)において、R1、R2及び*の符号は一
般式(B)のR1、R2及び*の符号と同じ意味を表わ
す。
(In the above general formula (B), R1 is a group having 1 to 12 carbon atoms selected from an alkyl group that may have an alkoxy group, a cycloalkyl group, and an aralkyl group having a heteroatom in an aromatic ring or an alkyl group. , R2 is a hydrogen atom or an easily removable protecting group selected from an acyl group, a silyl group, an aralkyl group, and an alkyloxyalkyl group; In the above general formula (P), R1, R2, and the symbols * represent the general formula The symbols R1, R2 and * in (B) have the same meanings.

上記一般式(P)におけるR1の具体例としては、メチ
ル2エチル、プロピル、イソプロピル。
Specific examples of R1 in the above general formula (P) include methyl 2-ethyl, propyl, and isopropyl.

ブチル、イソブヂル、ペンチル、インペンチル。Butyl, isobutyl, pentyl, impentyl.

2.2−ジメチルペンチル、ヘキシル、2−ヘキシル、
ヘプチル、2−ヘプチル、オクチル、2−オクチル、ノ
ニル、2−ノニル、デシル、2−デシル、ウンデシル、
2−ウンデシル、ドデシル。
2.2-dimethylpentyl, hexyl, 2-hexyl,
heptyl, 2-heptyl, octyl, 2-octyl, nonyl, 2-nonyl, decyl, 2-decyl, undecyl,
2-Undecyl, dodecyl.

2−エトキシ−1,1−ジメチルエチル、5−メトキシ
−1−メチルペンチル、シクロペンチル。
2-ethoxy-1,1-dimethylethyl, 5-methoxy-1-methylpentyl, cyclopentyl.

3−エチルシクロペンチル、シクロヘキシル。3-Ethylcyclopentyl, cyclohexyl.

2−メチルシクロヘキシル、4−ロープロピルシクロヘ
キシルなどのアルコキシ置換基を有していてもよい直鎖
状もしくは分岐状アルキル基又はシクロアルキル基、フ
ェニルオキシメチル、3−トリフルオロメチルフェニル
オキシメチル、2−クロロチオフェン−5−イルオキシ
メヂル、フランー2−イル−2−エチルなどの芳香環も
しくはアルキル基にペテロ原子を有するアラルキル基が
挙げられる。
Straight chain or branched alkyl groups or cycloalkyl groups which may have an alkoxy substituent such as 2-methylcyclohexyl, 4-lopropylcyclohexyl, phenyloxymethyl, 3-trifluoromethylphenyloxymethyl, 2- Examples include aralkyl groups having a petero atom in the aromatic ring or alkyl group, such as chlorothiophen-5-yloxymedyl and furan-2-yl-2-ethyl.

上記一般式(P)における水素原子以外のR2の具体例
としては、ベンゾイル、アセチル、p−フェニルベンゾ
イルなどのアシル基、t−ブチルメチルシリル、トリメ
チルシリル、 t−ブチルジフェニルシリルなどのシリ
ル基、ベンジル、4−ニトロフェニルメチルなどのアラ
ルキル基、テトラヒドロピラニル、 1−エトキシエチ
ルなどのアルキルオキシアルキル基等の容易に脱離可能
な基が挙げられる。
Specific examples of R2 other than hydrogen atoms in the above general formula (P) include acyl groups such as benzoyl, acetyl, and p-phenylbenzoyl, silyl groups such as t-butylmethylsilyl, trimethylsilyl, and t-butyldiphenylsilyl, and benzyl. , 4-nitrophenylmethyl, aralkyl groups, tetrahydropyranyl, 1-ethoxyethyl and other alkyloxyalkyl groups, and easily removable groups.

プロスタグランジンは生体内でプロスタグランジン合成
酵素によりアラキドン酸などの高級不飽和脂肪酸が化学
変換されて生じる極めて強い生理活性をもつ化合物で下
記のような構造を有している。
Prostaglandins are compounds with extremely strong physiological activity that are produced by chemical conversion of higher unsaturated fatty acids such as arachidonic acid by prostaglandin synthase in vivo, and have the following structure.

OH OH GF OH GE 天然のプロスタグランジンでは、R1はn−C3H11
−1Rは(CH2)a C0OH又はCH2CH=CH
(CH2)3 Coot−!であり、R1の置換基は脂
溶性を有することが生理活性の発現上重要であることが
知られている。医薬品としての開発研究が進められる中
でざらにR1としてアルキル基、シクロアルキル基又は
アラルキル基でおって炭素数4〜10のものが有効であ
り、例えばペンチル、イソペンチル、2.2−ジメチル
ペンチル、ヘキシル、2−ヘキシル、ヘプチル、2−エ
トキシ−1,1−ジメチルエチル、5−メトキシ−1−
メチルペンチルなどのアルキル基、シクロペンチル、3
−エチルシクロペンチル、4−プロピルシクロヘキシル
などのシクロアルキル基、フェニルオキシメヂル、3−
トリフルオロメチルフェニルオキシメチル、2−クロロ
チオフェン−5−イルオキシメチル、フラン−2−イル
−2−エチルなどのアラルキル基などが特に強い生理活
性を示すことが明らかにされてきた。本発明の化合物は
これら有機基を含めた置換基を導入することのできる原
料として有用なものである。
OH OH GF OH GE In natural prostaglandins, R1 is n-C3H11
-1R is (CH2)a C0OH or CH2CH=CH
(CH2)3 Coot-! It is known that it is important for the R1 substituent to have fat solubility for the expression of physiological activity. As R1 is being developed and researched as a pharmaceutical, an alkyl group, cycloalkyl group, or aralkyl group with 4 to 10 carbon atoms is generally effective, such as pentyl, isopentyl, 2,2-dimethylpentyl, Hexyl, 2-hexyl, heptyl, 2-ethoxy-1,1-dimethylethyl, 5-methoxy-1-
Alkyl groups such as methylpentyl, cyclopentyl, 3
-Cycloalkyl groups such as ethylcyclopentyl and 4-propylcyclohexyl, phenyloxymethyl, 3-
It has been revealed that aralkyl groups such as trifluoromethylphenyloxymethyl, 2-chlorothiophen-5-yloxymethyl, and furan-2-yl-2-ethyl exhibit particularly strong physiological activity. The compounds of the present invention are useful as raw materials into which substituents including these organic groups can be introduced.

本発明の上記一般式(P)で表わされるγ−ラクトン誘
導体の合成法を以下合成経路■に従って説明する。下記
において、Xはハロゲン原子、Mはアルカリ金属を表わ
す。
The method for synthesizing the γ-lactone derivative represented by the above general formula (P) of the present invention will be explained below according to synthetic route (2). In the following, X represents a halogen atom and M represents an alkali metal.

(1) (2) (2′ ) (6) (4) (7) (P) 上記反応において、ハロゲン化合物(1)にn−ブチル
リチウム、t−ブチルリチウム、メチルリチウム、リチ
ウムジイソプロピルアミドなどの強塩基を作用させてア
セチレン化合物(2)とし、ざらにこれらの強mlによ
りアルカリ金属アセチリド(2′)とする。これに光学
活性アルデヒド(3)を作用させると化合物(4)が得
られる。
(1) (2) (2') (6) (4) (7) (P) In the above reaction, n-butyllithium, t-butyllithium, methyllithium, lithium diisopropylamide, etc. are added to the halogen compound (1). Acetylene compound (2) is obtained by the action of a strong base, and alkali metal acetylide (2') is obtained by adding a strong ml of these. Compound (4) is obtained by reacting optically active aldehyde (3) with this.

上記アルカリ金属アセチリド(2′)は、上記のように
アセチレン化合物(2)を−度単離して再度強塩基と反
応させて調製してもよいが、より簡便にはハロゲン化合
物(1)を2倍量以上の強塩基と反応させて得られるア
ルカリ金属アセチリドをそのまま用いることができる。
The alkali metal acetylide (2') may be prepared by isolating the acetylene compound (2) as described above and reacting it again with a strong base, but more simply, the halogen compound (1) is Alkali metal acetylides obtained by reacting with twice or more of a strong base can be used as they are.

このアルカリ金属アセチリドと光学活性アルデヒド(3
)との反応は一78〜O′Cの低温で行うことが望まし
い。
This alkali metal acetylide and optically active aldehyde (3
) is preferably carried out at a low temperature of -78 to O'C.

化合物(4)を得る反応はテトラヒドロフラン。The reaction to obtain compound (4) is tetrahydrofuran.

ジイソプロピルエーテル、トルエンなどの不活性溶媒中
−78°C〜室温の温度範囲で行うことができる。この
反応によって得られる化合物(4)は下記化学式で示さ
れるようにエリトロ体(6−1>とトレオ体(6−2>
の混合物でおる。
It can be carried out in an inert solvent such as diisopropyl ether or toluene at a temperature range of -78°C to room temperature. Compound (4) obtained by this reaction is an erythro form (6-1>) and a threo form (6-2>) as shown in the following chemical formula.
Filter with a mixture of

OH この混合物からエリトロ体(6−1>又はトレオ体(6
−2>を選択的に得るにはカラム分離などによって分割
することができるが、後述するような化学的方法によっ
て簡便に、しかもより選択的にそれぞれの光学異性体を
製造することができる。この化合物(4)に酸化剤、例
えばCr03−ピリジン、ジメチルスルホキシド(DM
SO)−酸ハライドなどを用いて酸化することにより化
合物(5)のエチニルケトン誘導体を得ることができる
OH From this mixture, erythro form (6-1> or threo form (6-1)
-2> can be separated by column separation or the like, but each optical isomer can be easily and more selectively produced by a chemical method as described below. An oxidizing agent such as Cr03-pyridine, dimethyl sulfoxide (DM
The ethynyl ketone derivative of compound (5) can be obtained by oxidation using SO)-acid halide or the like.

この化合物(5)より光学活性エチニルアルコール誘導
体(6)を合成する反応は、得ようとするエチニルアル
コール誘導体(6)が前記化学式で示したエリトロ体(
6−1>であるか、またはトレオ体(6−2>でおるか
によって反応条件が異なる。即ち、エリトロ体(6,−
1>を目的とする場合は化合物(5)を水素化ホウ素亜
鉛釦体(Zn (8H4)2 >で、またトレオ体<6
−2>を目的とする場合はアルカリ金属セレクトリド、
例えばカリウムセレクトリドで還元することにより良好
な選択性をもって目的とする立体配置のエチニルアルコ
ール誘導体く6)を得ることができる。
In the reaction of synthesizing the optically active ethynyl alcohol derivative (6) from this compound (5), the ethynyl alcohol derivative (6) to be obtained is an erythro form (
The reaction conditions differ depending on whether it is the threo form (6-1> or the threo form (6-2>). That is, the erythro form (6, -
1>, the compound (5) is a borohydride zinc button body (Zn (8H4)2) or a threo body <6
-2> If the purpose is alkali metal selectride,
For example, by reduction with potassium selectride, the ethynyl alcohol derivative 6) having the desired configuration can be obtained with good selectivity.

上記エチニルアルコール誘導体(6)よりフリルアルコ
ール誘導体(7)を合成するには、エチニルアルコール
誘導体(6)に水素化リチウムアルミニウム等で三重結
合をトランス二重結合へ還元することによって得ること
ができる。この反応はテトラヒドロフラン、ジオキサン
等の不活性溶媒中40〜80℃の温度で行うことができ
る。
The furyl alcohol derivative (7) can be synthesized from the ethynyl alcohol derivative (6) by reducing the triple bond to a trans double bond in the ethynyl alcohol derivative (6) with lithium aluminum hydride or the like. This reaction can be carried out in an inert solvent such as tetrahydrofuran or dioxane at a temperature of 40 to 80°C.

アリルアルコール誘導体(7)は、下記一般式() %式%() (上記一般式(D)において、R4は炭素数1〜5の低
級アルキル基を表わす) で表わされるオルト酢酸トリアルキルと共に酸触媒の存
在下で加熱反応させ、ジョンソン−クライゼン転位反応
を行ってγ−不飽和カルボン酸誘導体(B)に変換され
る。用いる一般式(D>で表わされるオルト酢酸トリア
ルキルとしてはオルト酢酸トリメチル、オルト酢酸トリ
エチル、オルト酢酸トリプロピル、オルト酢酸トリブチ
ル、オルト酢酸トリヘプチル等が挙げられ、これをアリ
ルアルコール誘導体(7)に対して2〜10倍当量用い
、トルエン、キシレン、メシチレン等の溶媒中130〜
180℃の温度で反応が行われる。酸触媒としてはルイ
ス酸、ルイス酸8M体く例えば8F3・(C2Hs >
 20>やヘプタン酸などの有機酸が用いられる。この
ようにして得られたγ−不飽和カルボン酸誘導体(B)
のアセトニドを酸触媒で開環させ、分子内ラクトン化さ
せるとプロスタグランジン合成における鍵中間体である
本発明の一般式(P)で表わされる光学活性γ−ラクト
ン誘導体が得られる。この反応におけるアセトニドの加
水分解は含水有機酸、メタノール、エタノール等のアル
コール、アセトン又はジオキサンなどの溶媒中鉱酸やB
F3・エーテル錯体、CLJSO4゜ZnS″o4等の
ルイス酸又はルイス酸錯体を用いて室温〜80°Cの温
度で行うことができる。
The allyl alcohol derivative (7) is an acid together with trialkyl orthoacetate represented by the following general formula () % formula % () (In the above general formula (D), R4 represents a lower alkyl group having 1 to 5 carbon atoms) A heating reaction is carried out in the presence of a catalyst, and a Johnson-Claisen rearrangement reaction is carried out to convert the γ-unsaturated carboxylic acid derivative (B). Examples of the trialkyl orthoacetate represented by the general formula (D>) include trimethyl orthoacetate, triethyl orthoacetate, tripropyl orthoacetate, tributyl orthoacetate, triheptyl orthoacetate, etc. 130 to 10 times equivalent in a solvent such as toluene, xylene, mesitylene, etc.
The reaction is carried out at a temperature of 180°C. As acid catalysts, Lewis acids, Lewis acids 8M bodies, such as 8F3.(C2Hs >
20> and heptanoic acid are used. γ-unsaturated carboxylic acid derivative (B) thus obtained
When the acetonide is ring-opened with an acid catalyst and intramolecularly lactonized, an optically active γ-lactone derivative represented by the general formula (P) of the present invention, which is a key intermediate in prostaglandin synthesis, is obtained. Hydrolysis of acetonide in this reaction is carried out using water-containing organic acids, alcohols such as methanol and ethanol, mineral acids in solvents such as acetone or dioxane, and B.
It can be carried out at a temperature of room temperature to 80° C. using a Lewis acid or a Lewis acid complex such as F3.ether complex and CLJSO4°ZnS″o4.

このようにして得られた一般式(P)の化合物は、前記
G、 5torhらのプロスタグランジン合成法に従っ
てプロスタグランジン(前記PGE、PGF)に導くこ
とができる。従って本発明における一般式(P)の光学
活性化合物は、上記原料としては一般式(P)中の3位
、3゛位及び4位の立体配置は共にSであることが必要
とされる。
The compound of the general formula (P) thus obtained can be converted into prostaglandins (the above-mentioned PGE, PGF) according to the prostaglandin synthesis method of G. 5torh et al. Therefore, in the optically active compound of the general formula (P) in the present invention, the 3-, 3-, and 4-positions in the general formula (P) are all required to be S as the raw material.

上記反応にお(プる出発物質であるハロゲン化合物(1
)は、D−マンニトールや光学活性グリシドールから公
知の方法で得られる光学活性2,3−0−イソプロピリ
デングリセルアルデヒドをトリフェニルホスフィン及び
テトラハロメタンと反応させることにより容易に合成で
きる。
The halogen compound (1
) can be easily synthesized by reacting optically active 2,3-0-isopropylidene glyceraldehyde obtained from D-mannitol or optically active glycidol by a known method with triphenylphosphine and tetrahalomethane.

また、上記光学活性アルデヒド(3)は、下記合成経路
■に従って合成することができる。下記においで、R1
、R2及び*の符号は一般式(A>のR1,R2及び*
の符号と同様の意味を表わし、X、Yは、それぞれ独立
して水酸基、アシル基。
Further, the above-mentioned optically active aldehyde (3) can be synthesized according to the following synthetic route (2). In the following, R1
, R2 and * are the general formula (A> R1, R2 and *
, and X and Y each independently represent a hydroxyl group or an acyl group.

スルホキシ基及びハロゲン原子から選ばれた基又は原子
を表わす。
Represents a group or atom selected from a sulfoxy group and a halogen atom.

<C> (a) (d) (f) (3) 上記光学活性マンニトールをアセトンと酸触媒の存在下
で反応させてトリアセトニド(a)とし、これを含水酢
酸で部分加水分解してテトラオール(b)とし、これの
−級水酸基及び二級水酸基を各々別個にトリフェニルホ
スフィン−CCIla、酸ハライド−ピリジン、ピリジ
ン−メタンスルホニルクロリドなどで選択的にアシル基
、スルホキシ基又はハロゲン原子で一部又は全部を変換
してアセトニド<C>とする。次いでこのアセトニド(
C)を塩基でジエボキシド(d>とした後、R3MgB
r、R3MClBr−Cu2  (CN)2゜R3Lj
(但し、R3はR1より炭素数が1個少ない基を表わす
)や水素化リチウムアルミニウムなどでR1基を導入し
、さらに水酸基をR2X’(X’ はハロゲン原子又は
スルホキシ基)と反応させてアセトニド(e)とし、こ
れを加水分解してジオール(f)とした後、Pb (O
Ac)aやNal0aなどで酸化して目的の光学活性ア
ルデヒド(3)を1@ることができる。
<C> (a) (d) (f) (3) The above optically active mannitol is reacted with acetone in the presence of an acid catalyst to form triacetonide (a), which is partially hydrolyzed with hydrous acetic acid to form tetraol ( b), and its -class hydroxyl group and secondary hydroxyl group are selectively treated with triphenylphosphine-CCIla, acid halide-pyridine, pyridine-methanesulfonyl chloride, etc., partially or with an acyl group, sulfoxy group, or halogen atom. All are converted to acetonide <C>. Then this acetonide (
After converting C) to dieboxide (d>) with a base, R3MgB
r, R3MClBr-Cu2 (CN)2゜R3Lj
(However, R3 represents a group with one less carbon number than R1) or lithium aluminum hydride, etc., and the hydroxyl group is further reacted with R2X'(X' is a halogen atom or a sulfoxy group) to form acetonide. (e), and after hydrolyzing this to obtain diol (f), Pb (O
The desired optically active aldehyde (3) can be obtained by oxidation with Ac)a, Nal0a, etc.

以下実施例によって本発明を説明する。The present invention will be explained below with reference to Examples.

(実 施 例) 実施例 く化合物(a)の合成〉 45gのD−マンニトールをアセトン1p及び濃塩酸1
d中で至温下3日間激しく撹拌した後、炭酸カリウム5
0(]を加え、さらに1日撹拌した。固形物を吸引濾過
して除き、濾液中の溶媒を減圧下に留去し、得られた残
渣に水を加え、析出した結晶を吸引濾取して粗生成物4
5(Jを1qた。これをエタノール20m1に加熱溶解
した後濾過し、濾液を至温に冷却して析出した結晶を濾
取し、下記化学式で示される光学活性(2R,3R,4
R,5R)体のトリアセトニド(a)  37.3g(
収率50%)を得た。
(Example) Synthesis of Example Compound (a)> 45 g of D-mannitol was mixed with 1 part of acetone and 1 part of concentrated hydrochloric acid.
After stirring vigorously for 3 days at maximum temperature in d, potassium carbonate 5
0 () was added and the mixture was further stirred for 1 day.The solid matter was removed by suction filtration, the solvent in the filtrate was distilled off under reduced pressure, water was added to the resulting residue, and the precipitated crystals were collected by suction filtration. Crude product 4
1 q of 5 (J) was dissolved by heating in 20 ml of ethanol and then filtered. The filtrate was cooled to a very low temperature and the precipitated crystals were collected by filtration.
R,5R) triacetonide (a) 37.3g (
A yield of 50% was obtained.

ン50dで再結晶して下記化学式で示される光学活性(
2R,3R,4R,5R)体のテトラオール(b)a、
aC)(収率80%)を得た。
The optical activity (
2R, 3R, 4R, 5R) tetraol (b)a,
aC) (yield 80%) was obtained.

’HNMR(CC1a ) δ:1.40    < 6H,S、CH3X2 >1
.43    (12H,S、 CH3X4 )3.7
〜4.4  (8H,m、 CH2、Cf−1)〈化合
物(b)の合成〉 上記得られたトリアセトニド(a>  15g(0,0
5…01)を70%酢酸50d中40’Cで3.5時間
撹拌した後、40℃で出来丈速やかに減圧濃縮し、残渣
にアセトンを加え結晶化したD−マンニトール(0,7
2g>を濾別し、濾液よりアセトンを減圧留去してシロ
ップ状の生成物を得た。これをペンゼ’HNMR(D2
 0) δ:1.3B    (6H,S、CH3X2 )3.
3〜4.2  (8H,m、CH2、CH)〈化合物(
C)及び(d)の合成〉 上記得られたテトラオール(b)  15.3(](0
,089mol) 、無水ピリジン55d (0,68
mol)、CH2CJ1250mlの溶液中に、−70
℃で塩化ヘンソイル16m (0,138mol > 
、無水CH2Cl25m1lの混合液を15分間かけて
滴下し、滴下後更に一30’Cで1時間、字部で10時
間撹拌し、反応の完結をN層りロマトグラフで確認した
後溶媒を減圧留去した。
'HNMR (CC1a) δ: 1.40 < 6H,S, CH3X2 > 1
.. 43 (12H,S, CH3X4)3.7
~4.4 (8H, m, CH2, Cf-1) <Synthesis of compound (b)> Triacetonide obtained above (a> 15 g (0,0
D-mannitol (0,7
2g> was separated by filtration, and acetone was distilled off from the filtrate under reduced pressure to obtain a syrup-like product. This was analyzed by Penze'HNMR (D2
0) δ:1.3B (6H,S,CH3X2)3.
3-4.2 (8H, m, CH2, CH)〈Compound (
Synthesis of C) and (d)> Tetrol (b) obtained above 15.3(](0
,089 mol), anhydrous pyridine 55d (0,68
-70 mol), in a solution of 1250 ml of CH2CJ
Hensoil chloride 16m (0,138mol >
A mixed solution of 25 ml of anhydrous CH2Cl was added dropwise over a period of 15 minutes, and after the dropwise addition, the mixture was further stirred at -30'C for 1 hour and then at the bottom for 10 hours. After confirming the completion of the reaction with an N-layer romatograph, the solvent was distilled off under reduced pressure. did.

この残渣にメタンスルホニルクロリド11.2d(0,
144mol )を0℃で20分間かけて加え、更にこ
の懸濁液を字部で3日間撹拌した。反応の完結を薄層ク
ロマトグラフで確認した後、反応混合物にエチルエーテ
ル:ヘキサン=7:3(容量)の混合溶媒100威を加
え、この黄色の懸濁液をセライト−545で濾過し、溶
媒を減圧留去した。1qられた褐色の残渣をCH2Cl
2で希釈し、濃塩酸を加えて酸性にしだ後CH2Cbで
3回抽出した。抽出物を飽和重曹水、飽和食塩水で順次
洗浄した後無水硫酸マグネシウムで乾燥し、溶媒を減圧
留去して下記化学式で示される光学活性(2R,3R,
4R。
To this residue was added 11.2 d of methanesulfonyl chloride (0,
144 mol) was added over 20 minutes at 0°C, and the suspension was further stirred at the bottom for 3 days. After confirming the completion of the reaction by thin layer chromatography, 100 parts of a mixed solvent of ethyl ether:hexane = 7:3 (by volume) was added to the reaction mixture, and the yellow suspension was filtered through Celite-545 to remove the solvent. was distilled off under reduced pressure. 1q of the brown residue was dissolved in CH2Cl.
The mixture was diluted with 2 and acidified with concentrated hydrochloric acid, and then extracted with CH2Cb three times. The extract was washed successively with saturated aqueous sodium bicarbonate and saturated brine, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain optically active compounds (2R, 3R,
4R.

5R)体の褐色半固体物アセトニド(C)42(]を得
(但し、MSはメチルスルホキシ基、phは)工二ル基
を表わす) 上記アセトニド(c)42g、K2 C0320gをメ
タノール130威中で15時間撹拌した後、反応液をセ
ライト−545を通して濾過し、濾液を40’Cで減圧
濃縮し、エチルエーテル:ヘキサン=7:3(容量)の
混合溶媒30m1を加えて再度セライト−545で濾過
し、溶媒を40℃で減圧留去し、さらに減圧蒸沼により
粗生成物を得た。これをざらにベンゼンで再結晶して純
粋な下記化学式で示される光学活性(23,3R,4R
,5S)体のジエボキシド(d ) 2.7(] (収
率21%)を得た。
Acetonide (C) 42(), a brown semi-solid substance of 5R) body, was obtained (where MS is a methyl sulfoxy group and pH is an engineering group). After stirring for 15 hours, the reaction solution was filtered through Celite-545, the filtrate was concentrated under reduced pressure at 40'C, 30 ml of a mixed solvent of ethyl ether:hexane = 7:3 (volume) was added, and the mixture was filtered through Celite-545 again. The solvent was distilled off under reduced pressure at 40°C, and a crude product was obtained by steaming under reduced pressure. This is roughly recrystallized from benzene to obtain a pure optically active product (23,3R,4R
, 5S) dieboxide (d) 2.7(] (yield 21%) was obtained.

(C) ’HNMR(CD(llff13 ) δ:t39    (6H,S、CH3X2 )2.6
〜2.9  (4H,m、 CH2X2 )2.95〜
3.12 (2H,m、  CH)3.7〜3.95 
(2H,m、CH)〈化合物(e)及び(f)の合成〉 Cu2  (CN)2 320mg、無水テトラヒドロ
フラン100mIlの混合物に、別途調製した濃度1.
47nofのn−ブチルマグネシウムプロミドのエーテ
ル溶液64d (94m mol )を0℃で5分間か
けて加えた。ざらに5分間撹拌した後、上記得られたジ
エポキシド(d)  6.48(]の無水テトラヒドロ
フラン50r111溶液を0°Cで撹拌下10分間かけ
て滴下し、ざらに1時間撹拌した。反応の完結を薄層ク
ロマトグラフで確認した後、NH4αと飽和食塩水で分
解し、30分間撹拌後、エチルエーテルで3回抽出し、
エーテル層を1規定塩酸、飽和重曹水、飽和食塩水で順
次洗浄し、無水硫酸マグネシウムで乾燥して濾過し、濾
液の溶媒を留去して下記化学式で示される光学活性(6
3,7R,8R,98)体の粗ジオール(e−1>を得
た。
(C) 'HNMR (CD(llff13) δ:t39 (6H,S,CH3X2)2.6
~2.9 (4H, m, CH2X2)2.95~
3.12 (2H, m, CH) 3.7-3.95
(2H, m, CH) <Synthesis of compounds (e) and (f)> A separately prepared concentration 1.
A solution of 47nof of n-butylmagnesium bromide in ether 64d (94 mmol) was added over 5 minutes at 0°C. After roughly stirring for 5 minutes, a solution of diepoxide (d) 6.48 () obtained above in 50r111 of anhydrous tetrahydrofuran was added dropwise over 10 minutes with stirring at 0°C, and the mixture was roughly stirred for 1 hour.Completion of the reaction. After confirming by thin-layer chromatography, it was decomposed with NH4α and saturated saline, stirred for 30 minutes, extracted three times with ethyl ether,
The ether layer was sequentially washed with 1N hydrochloric acid, saturated sodium bicarbonate solution, and saturated brine, dried over anhydrous magnesium sulfate, filtered, and the solvent of the filtrate was distilled off to obtain the optically active (6
3,7R,8R,98) crude diol (e-1>) was obtained.

上記得られた粗ジオール(e−1)を無水テトラヒドロ
フラン30m1に溶かし、これに水素化ナトリウム0.
48g (1,07m mol )の無水テトラヒドロ
フラン100威を還流下15分間かけて滴下し、ざらに
1時間撹拌還流した後0’Cに冷却した。この懸濁液に
DC−18−クラウンエーテル−6132mgと臭化ベ
ンジル9.、W (78m mol )を0℃で加えて
4時間撹拌還流した。反応液を減圧濃縮し、1規定塩酸
で分解した後ヘキサンで3回抽出し、抽出液を飽和重曹
水、飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥
した後溶媒を減圧留去して下記化学式で示される光学活
性(63,7R,8R,9S)体のアセトニド(e−2
>を得た。
The crude diol (e-1) obtained above was dissolved in 30 ml of anhydrous tetrahydrofuran, and 0.0 mL of sodium hydride was added to the solution.
48 g (1.07 mmol) of 100 parts of anhydrous tetrahydrofuran was added dropwise over 15 minutes under reflux, and the mixture was roughly stirred and refluxed for 1 hour, and then cooled to 0'C. To this suspension were added 6132 mg of DC-18-crown ether and 9.1 mg of benzyl bromide. , W (78 mmol) were added at 0°C, and the mixture was stirred and refluxed for 4 hours. The reaction solution was concentrated under reduced pressure, decomposed with 1N hydrochloric acid, extracted three times with hexane, the extract was washed with saturated aqueous sodium bicarbonate and saturated brine, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. Acetonide (e-2) of the optically active (63,7R,8R,9S) form shown by the chemical formula
> obtained.

OH0Bn (但し、Bnはベンジル基を表わす) 上記アセトニド(e−2>を80%酢酸100m1中1
00℃で10時間加熱撹拌した後、溶媒を減圧留去し、
次いでエチルエーテルで抽出し、抽出液を苛性ソーダ水
溶液で洗浄し、水層はざらにエチルエーテルで抽出し、
これらエーテル層を併せて1規定塩酸、飽和重曹水、食
塩水で順次洗浄して無水硫酸マグネシウムで乾燥した。
OH0Bn (However, Bn represents a benzyl group) The above acetonide (e-2> was dissolved in 100 ml of 80% acetic acid.
After heating and stirring at 00°C for 10 hours, the solvent was distilled off under reduced pressure.
Next, it was extracted with ethyl ether, the extract was washed with an aqueous solution of caustic soda, and the aqueous layer was roughly extracted with ethyl ether.
These ether layers were combined, washed successively with 1N hydrochloric acid, saturated sodium bicarbonate solution, and brine, and dried over anhydrous magnesium sulfate.

溶媒を沼去後シリカゲルカラムクロマトグラフィーで精
製しくエチルエーテル:ヘキサン=1:4(容量)で溶
出)、下記化学式で示される光学活性(6S、 7R,
8f?、 9S)体のジオール(f)  8.66g(
化合物(d>よりの収率55%)を得た。
After removing the solvent, it was purified by silica gel column chromatography and eluted with ethyl ether:hexane = 1:4 (volume)), and the optical activity represented by the following chemical formula (6S, 7R,
8f? , 9S) diol (f) 8.66 g (
A compound (yield 55% from d>) was obtained.

(但し、Bnはベンジル基を表わす) ’HNMR(CDC13) δ:0.88    (6H,br、CH:l X2 
)1.0〜1.8  (t6H,m、 CH2X8 )
3.4〜3.7  (4H,m、CH)4.46   
 (2H,d、 J=10.8Hz、 CH)4.62
    (2H,d、 J=10.81(z、 CH)
7.30    (10H,S、C6H5)〈化合物(
3)の合成〉 上記得られたジオール(f)  200mg、K2 C
0360m(J及び無水ベンゼン4.5d中に四酢酸鉛
260mgを4°Cで加えて3分間撹拌した。反応終了
後ヘキサン100Ir11を加え、セライト−545を
用いて濾過し、濾液を飽和重曹水で洗浄し、水層をヘキ
サンで2回抽出し、ヘキサン層を併せて飽和食塩水で洗
浄した後無水硫酸マグネシウムで乾燥した。溶媒を留去
後、シリカゲルカラムクロマトグラフィー(エチルエー
テル:ヘキサン=1:2 (容量))で精製して(S)
−2−ベンジルオキシヘプタナール(3)160mg(
収率80%)を得た。
(However, Bn represents a benzyl group) 'HNMR (CDC13) δ: 0.88 (6H, br, CH: l X2
)1.0~1.8 (t6H,m, CH2X8)
3.4-3.7 (4H, m, CH) 4.46
(2H, d, J=10.8Hz, CH)4.62
(2H, d, J=10.81(z, CH)
7.30 (10H,S,C6H5)〈Compound (
Synthesis of 3)> 200 mg of the diol (f) obtained above, K2C
0360m (J) and 260mg of lead tetraacetate were added to 4.5d of anhydrous benzene at 4°C and stirred for 3 minutes. After the reaction, 100Ir11 of hexane was added, filtered using Celite-545, and the filtrate was diluted with saturated sodium bicarbonate solution. The aqueous layer was extracted twice with hexane, and the hexane layers were combined and washed with saturated brine, then dried over anhydrous magnesium sulfate. After distilling off the solvent, silica gel column chromatography (ethyl ether:hexane=1: 2 (volume)) and purified with (S)
-2-benzyloxyheptanal (3) 160 mg (
A yield of 80% was obtained.

(但し、Bnはベンジル基を表わす) ’HNMR(CDCex ) δ:0.87    (3H,t、 J= 5.8Hz
(However, Bn represents a benzyl group) 'HNMR (CDCex) δ: 0.87 (3H, t, J = 5.8Hz
.

CH3) 1.0〜1.8  (8H,m、 CH2)3.73 
   (IH,dt、 J= 2.2Hz。
CH3) 1.0-1.8 (8H, m, CH2) 3.73
(IH, dt, J = 2.2Hz.

6.2H2,CH) 4.51       (IH,d、  J=11.6
H2,CH)4.65    (IH,d、 J=11
.6H7,CH)7.34     (5H,S、 C
6Hs >9.64     (IH,d、 J= 2
.2H2)〈化合物(4)の合成〉 下記化学式(1) で表わされる(S)−ジブロマイド4.8C1(16,
13mmo1)の無水テトラヒドロフラン100I11
Nを一78℃に冷却し、窒素雰囲気下で濃度1.62m
olのプチルリヂウムーヘキサン溶液16.4m!(2
6,6m mol )を10分間かけて滴下し、−78
℃でざらに1時間、室温で1時間撹拌して光学活性リチ
ウムアセチリド(2′)に変換し、これを−78℃に冷
却して上記得られた(S)−2−ベンジルオキシヘプタ
ナール(3)  2.41(1(4,4111m01>
の無水テトラヒドロフラン20m1を滴下し、30分間
更に撹拌した後、塩化アンモニウム水溶液で分解し、エ
チルエーテルで3回抽出して飽和食塩水で洗浄した後無
水硫酸マグネシウムで乾燥した。溶媒を減圧留去し、シ
リカゲルカラムクロマトグラフィー(エチルエーテルニ
ヘキサン=1:3(容量))で精製して下記化学式(4
)で表わされる(28.63>体の化合物3. slg
を得たく収率64%)。このものはエリトロ体ニドレオ
体−64: 36 (重量〉の混合物であった。
6.2H2,CH) 4.51 (IH,d, J=11.6
H2, CH) 4.65 (IH, d, J=11
.. 6H7,CH)7.34 (5H,S,C
6Hs >9.64 (IH, d, J= 2
.. 2H2) <Synthesis of compound (4)> (S)-dibromide 4.8C1 (16,
13 mmol 1) of anhydrous tetrahydrofuran 100I11
N was cooled to -78℃ and the concentration was 1.62m under nitrogen atmosphere.
Butyllidium hexane solution of ol 16.4m! (2
6.6 mmol) was added dropwise over 10 minutes, and -78
The mixture was stirred for roughly 1 hour at ℃ and 1 hour at room temperature to convert it into optically active lithium acetylide (2'), which was then cooled to -78℃ to convert the above-obtained (S)-2-benzyloxyheptanal ( 3) 2.41(1(4,4111m01>
20 ml of anhydrous tetrahydrofuran was added dropwise, and after further stirring for 30 minutes, the mixture was decomposed with an aqueous ammonium chloride solution, extracted three times with ethyl ether, washed with saturated brine, and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure and purified by silica gel column chromatography (ethyl ether nihexane = 1:3 (volume)) to obtain the following chemical formula (4
) Represented by (28.63> compound 3. slg
yield of 64%). This product was a mixture of erythro-nidoreo-64 and 36 (weight).

(但し、Bnはベンジル基を表わす) 〈化合物(5)の合成〉 無水ジメチルスルホキシド680mg (8,7m m
ol >の無水塩化メチレン157!溶液にオキザリル
ジクロリド0.38d (4,4m mol )を−7
0℃で5分間かけて滴下し、ざらに10分間同温度で撹
拌した。これに上記得られたエリトロ体ニドレオ体−6
4: 38の化合物(4)  1.0012.9mmo
l>の無水塩化メチレン4mlを滴下し9分間−70℃
で撹拌した。これに無水トリエチルアミン2.0rdl
(14m mol )を滴下して徐々に室温に戻した後
ヘキサンを加え、セライト−545を通して濾過し、濾
液を1規定塩酸で洗浄した。水層を塩化メチレンで3回
抽出し、抽出物を飽和食塩水で洗浄し無水¥JR酸マグ
ネシウムで乾燥した。溶媒を減圧留去し、シリカゲルカ
ラムクロマトグラフィー(エチルエーテル:ヘキサン=
1:10(容量))で精製し、下記化学式で示される(
23.63>体の工′チニルケトン誘導体(5)550
m(]を得た(収率55%)。
(However, Bn represents a benzyl group) <Synthesis of compound (5)> 680 mg of anhydrous dimethyl sulfoxide (8.7 mm
ol > anhydrous methylene chloride 157! Add 0.38 d (4.4 mmol) of oxalyl dichloride to the solution at -7
The mixture was added dropwise at 0° C. over 5 minutes and roughly stirred at the same temperature for 10 minutes. In addition to this, the erythro body Nidoreo body-6 obtained above
4: 38 compound (4) 1.0012.9mmo
4 ml of anhydrous methylene chloride was added dropwise at -70°C for 9 minutes.
It was stirred with Add to this 2.0rdl of anhydrous triethylamine
(14 mmol) was added dropwise and the temperature was gradually returned to room temperature, then hexane was added and the mixture was filtered through Celite-545, and the filtrate was washed with 1N hydrochloric acid. The aqueous layer was extracted three times with methylene chloride, and the extract was washed with saturated brine and dried over anhydrous magnesium JR acid. The solvent was distilled off under reduced pressure and subjected to silica gel column chromatography (ethyl ether:hexane=
1:10 (volume)) and purified with the following chemical formula (
23.63>-modinyl ketone derivative (5) 550
m(] was obtained (yield 55%).

(但し、3nはペンシル基を表わす) ’HNMR(CDCb ) δ :0.86        (3H,br    
t、  J=  7.2NZ。
(However, 3n represents a pencil group) 'HNMR (CDCb) δ: 0.86 (3H, br
t, J=7.2NZ.

CH3) 1.0〜1.9  (8H,m、 CH2)1.38 
   (3H,s、CH3)1.47    (3H,
S、CH3)4.02    (1H,dd、 J= 
5.6Hz。
CH3) 1.0-1.9 (8H, m, CH2) 1.38
(3H, s, CH3) 1.47 (3H,
S, CH3) 4.02 (1H, dd, J=
5.6Hz.

8.241+2. CH) 4.18    (II−(、dd、 J= 6.4H
2゜8.24Hz、 CH) 4.42    (IH,d、 J=11.5H2,C
H)4.70    、(1H,d、 J=11.5H
2,CH)4.86    (1H,dd、 J= 5
.6Hz。
8.241+2. CH) 4.18 (II-(, dd, J= 6.4H
2゜8.24Hz, CH) 4.42 (IH, d, J=11.5H2,C
H) 4.70, (1H, d, J=11.5H
2, CH) 4.86 (1H, dd, J= 5
.. 6Hz.

6.4H7,CH) 7.31    (5H,S、 Cc+ Hs )IR
l/maX  (neat> 695、 735. 835.1060.1220.1
320゜1370、1380.1450.1675.2
200.2860゜2920、3020cnrl 〈化合物(6)の合成〉 上記得られた(23.6S)体のエチニルケトン誘導体
(5)  550mg(1,6mmol)の無水エーテ
ル16m1中へ一30’Cで濃度0.26…01の水素
化ホウ素亜鉛−エチルエーテル溶液9.6d (2,5
m mol )を窒素雰囲気下5分間かけて滴下し、ざ
らに30分間撹拌した。反応終了後、水及び0.5規定
塩駿20m1を加え、0℃で30分間撹拌した。水層を
エチルエーテルで3回抽出し、抽出液を飽和重曹水及び
飽和食塩水で順次洗浄し無水硫酸マグネシウムで乾燥し
た。溶媒を減圧召人し、シリカゲルカラムクロマトグラ
フィー(エチルエーテル:へキサン=1:3 (容量)
)で精製して下記化学式で示される(2S、 5R,6
3)体のエチニルアルコール誘導体(6)(エリトロ体
ニドレオ体=90 : 10 (重量))349mgを
得た(収率63%)。
6.4H7,CH) 7.31 (5H,S, Cc+Hs)IR
l/maX (neat> 695, 735. 835.1060.1220.1
320°1370, 1380.1450.1675.2
200.2860゜2920,3020cnrl <Synthesis of compound (6)> Ethynyl ketone derivative (5) of the (23.6S) form obtained above was added to 550 mg (1.6 mmol) of anhydrous ether 16 ml at -30'C. 0.26...01 zinc borohydride-ethyl ether solution 9.6d (2,5
mmol) was added dropwise over 5 minutes under a nitrogen atmosphere, and the mixture was roughly stirred for 30 minutes. After the reaction was completed, water and 20 ml of 0.5N Shioshun were added, and the mixture was stirred at 0°C for 30 minutes. The aqueous layer was extracted three times with ethyl ether, and the extract was washed successively with saturated aqueous sodium bicarbonate and saturated brine, and dried over anhydrous magnesium sulfate. Remove the solvent under reduced pressure and perform silica gel column chromatography (ethyl ether:hexane = 1:3 (volume)).
) and purified by the following chemical formula (2S, 5R, 6
349 mg of the ethynyl alcohol derivative (6) (erythro form and nidoleo form = 90:10 (weight)) was obtained (yield: 63%).

(但し、Bnはベンジル基を表わす) ’HNMR(CDCb ) δ:0.87    (3H,br  t、 J= 7
.2Hz。
(However, Bn represents a benzyl group) 'HNMR (CDCb) δ: 0.87 (3H, br t, J = 7
.. 2Hz.

CH3) 1.0〜1.8  (8H,m、 CH2)1.36 
   (3H,S、CH3)1.45    (3H,
S、CH3)3.49    (IH,dt、 J= 
3.8H2゜6.4H2,CH) 3.88    (IH,dd、 J= 6.4H2゜
7.7H2,CH) 4.12    (IH,dd、 J= 6.4Hz。
CH3) 1.0-1.8 (8H, m, CH2) 1.36
(3H,S,CH3)1.45 (3H,
S, CH3) 3.49 (IH, dt, J=
3.8H2゜6.4H2, CH) 3.88 (IH, dd, J = 6.4H2゜7.7H2, CH) 4.12 (IH, dd, J = 6.4Hz.

7.7H7,CH) 4.4〜4.7  (11−1,m、 J= 1.5H
z。
7.7H7,CH) 4.4~4.7 (11-1,m, J= 1.5H
z.

3.8+12. CH) 4.59    (2H,s、CH2)4.69   
 (11−1,ddd、 J= 1.5Hz。
3.8+12. CH) 4.59 (2H, s, CH2) 4.69
(11-1, ddd, J= 1.5Hz.

6.4H2,6,4H2,CH) 7.30    (5H,S、 Cs Hs )” C
NMR(CDCI13) δ:  13.98. 22.54. 25.27. 
25゜96. 26.22゜30.0&、  31.8
5. 64.16. 65.57. 69.94゜72
.49. 81.50. 83.70. 84.00.
100.31゜127.83.128.40.138.
21〈化合物〈7)の合成〉 上記得られた(2S、 5R,68)体のエチニルアル
コール誘導体(6)  10bmc+ (0,30m 
mol)の無水テトラヒドロ7ラン2d溶液を水素化リ
チウムアルミニウム24.1mg(0,63m mol
>の無水テトラヒドロフラン5ml中にO′Cで加え、
18分間撹拌還流した。反応終了後、酢酸エチル、エタ
ノール、水、0.1規定塩酸を順次加えて分解し、水層
をエチルエーテルで2回抽出した。抽出液を飽和食塩水
で洗浄し、無水硫酸マグネシウムで乾燥後、溶媒を減圧
留去し、シリカゲルカラムクロマトグラフィー(エチル
エーテル:ヘキサン=1:3(容量))で精製して下記
化学式で示される(23.5R,63)体のアリルアル
コール誘導体< 7 ) 80.1mgを得た(収率7
6%)。
6.4H2,6,4H2,CH) 7.30 (5H,S, Cs Hs)”C
NMR (CDCI13) δ: 13.98. 22.54. 25.27.
25°96. 26.22゜30.0&, 31.8
5. 64.16. 65.57. 69.94°72
.. 49. 81.50. 83.70. 84.00.
100.31°127.83.128.40.138.
21 <Synthesis of compound <7)> Ethynyl alcohol derivative (6) of the (2S, 5R,68) form obtained above 10bmc+ (0,30m
24.1 mg (0.63 m mol) of lithium aluminum hydride was added to anhydrous tetrahydro 7 run 2d solution
> into 5 ml of anhydrous tetrahydrofuran at O'C,
Stir and reflux for 18 minutes. After the reaction was completed, ethyl acetate, ethanol, water, and 0.1N hydrochloric acid were sequentially added for decomposition, and the aqueous layer was extracted twice with ethyl ether. The extract was washed with saturated brine, dried over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure, and purified by silica gel column chromatography (ethyl ether:hexane = 1:3 (volume)) to obtain a product represented by the chemical formula below. (23.5R,63) allyl alcohol derivative <7) 80.1 mg was obtained (yield 7).
6%).

(但し、3nはベンジル基を表わす) ’HNMR(、CDCb ) δ 二0.86       (3H,t、  J= 
 5.4Hz。
(However, 3n represents a benzyl group) 'HNMR (, CDCb) δ 20.86 (3H, t, J=
5.4Hz.

CH3) 1.38    (3H,S、CH3)1.40   
     (3H,s、  CH3)1.04〜4.8
  (8H,m、 CH2)3.2〜3.5  (IH
,m、 Ct−()3.52    (IH,dd、 
J= 7.7tlz。
CH3) 1.38 (3H, S, CH3) 1.40
(3H,s, CH3) 1.04-4.8
(8H, m, CH2) 3.2~3.5 (IH
, m, Ct-()3.52 (IH, dd,
J = 7.7tlz.

7.7Hz、 CH) 4.08    (什1. dd、 J= 6.4H2
゜8、OH2,C)−1> ”CNMR(CDCb ) δ:14゜02. 22.61. 25.46. 25
.92. 26.72゜29.42. 31.93. 
69.44. 72゜22. 72.56゜82.18
.127.72.127.79.128.40.129
.89゜132.47.140.60 く化合物(B)の合成〉 上記得られた(23.5R,63)体のアリルアルコー
ル誘導体(7) 80.1m(] (00,23mmo
l ) 、トリエチルオルトアセテート0.15m1(
0,82m mol )及び触媒量のヘプタノイックア
シッドをキシレン3d中160°Cで20分間加熱反応
させ、キシレンと生成したエタノールを減圧預入し、反
応終了後飽和重曹水で分解した。水層をエチルエーテル
で2回抽出し、抽出物を飽和食塩水で洗浄した後無水硫
酸マグネシウムで乾燥した。溶媒を減圧留去後、シリカ
ゲルカラムクロマトグラフィー(エチルエーテル:ヘキ
゛リン=1:10(容量))で精製して下記化学式で示
される(1°S、 38.63)体のγ−不飽和カルボ
ン酸エチル(B ) 65.6mgを得た(収率68%
)。
7.7Hz, CH) 4.08 (1.dd, J= 6.4H2
゜8, OH2, C)-1>"CNMR (CDCb) δ: 14゜02.22.61.25.46.25
.. 92. 26.72°29.42. 31.93.
69.44. 72°22. 72.56°82.18
.. 127.72.127.79.128.40.129
.. 89゜132.47.140.60 Synthesis of compound (B)〉 Allyl alcohol derivative (7) of the (23.5R,63) form obtained above 80.1m(] (00,23mmo
l ), triethyl orthoacetate 0.15 ml (
0.82 mmol) and a catalytic amount of heptanoic acid were heated and reacted in xylene 3d at 160°C for 20 minutes, the xylene and the produced ethanol were deposited under reduced pressure, and after the reaction was completed, they were decomposed with saturated sodium bicarbonate solution. The aqueous layer was extracted twice with ethyl ether, and the extract was washed with saturated brine and dried over anhydrous magnesium sulfate. After evaporating the solvent under reduced pressure, the product was purified by silica gel column chromatography (ethyl ether: hexin = 1:10 (volume)) to obtain the (1°S, 38.63) form of γ-unsaturated carboxylic acid represented by the chemical formula below. 65.6 mg of ethyl (B) was obtained (yield 68%).
).

(B) (但し、Bnはベンジル基を表わす) ’HNMR(CDCI13) δ:0.86    (3H,br  t、 J= 7
.2Hz。
(B) (However, Bn represents a benzyl group) 'HNMR (CDCI13) δ: 0.86 (3H, br t, J = 7
.. 2Hz.

CH3) 1.0 〜1.8   (8H,m、  CH2)1.
33    (3H,S、CH3)1.41    (
3H,S、CH3)2.40    (IH,dd、 
J= 9.0Hz。
CH3) 1.0 to 1.8 (8H, m, CH2)1.
33 (3H,S,CH3)1.41 (
3H, S, CH3) 2.40 (IH, dd,
J = 9.0Hz.

14.7Hz、 CH) 2.50    (IH,dd、 J= 5.1Hz。14.7Hz, CH) 2.50 (IH, dd, J = 5.1Hz.

14.7H2,CH) 2.6〜3.0  (IH,m、CH)3.5〜3.8
  < 2t−1,m、 CH2)3.9〜4.3  
(2H,m、CHx2 >4.09     (2H,
Q、 J= 7゜2tlz。
14.7H2, CH) 2.6-3.0 (IH, m, CH) 3.5-3.8
<2t-1,m, CH2) 3.9~4.3
(2H, m, CHx2 >4.09 (2H,
Q, J= 7°2tlz.

Cf−ho) 4.31     (IH,d、 J=11.7NZ。Cf-ho) 4.31 (IH, d, J=11.7NZ.

CH208H5) 4.55    (IH,d、 J=11.7112゜
CH2C8H5) 5.2〜5.7  (2H,m、=Chl−)7.27
        (5日、  S、  06 H5)”
CNMR(CDCfh ) δ :   14.00.  14.25.  22.
59.  25.03.  26.30゜31.77、
 35.72. 3B、50. 41.77、 60.
32゜6&、81. 69.79. 77.30. 7
9.74.109.08゜127.28.127.72
.128.20.130.84.134.45゜139
.00.171.79 く化合物(P)の合成〉 士、記11られた(1“S、 3S、 6S)体のγ−
不飽和カルボン酸エチル(B ) 65m(J (0,
16m not ) 、メタノール5Uil、水1.2
5d及びCuSO4・5H20186mg(0,75m
 mof>を13時間撹拌還流した。反応終了後、エチ
ルエーテルを加えてセライト−545により濾過し、濾
液を飽和食塩水で洗浄した後無水ば1酸マグネシウムで
乾燥した。溶媒を減圧留去後、シリカゲルカラムクロマ
トグラフィー(酢酸エチル:ヘキサン=1:5(容母)
)で精製して下記化学式で示される(33. 3’S、
 43>体のγ−ラクトン誘導体(P)35.5mgを
得た(収率69%)。
CH208H5) 4.55 (IH, d, J=11.7112°CH2C8H5) 5.2~5.7 (2H, m, = Chl-) 7.27
(5th, S, 06 H5)”
CNMR (CDCfh) δ: 14.00. 14.25. 22.
59. 25.03. 26.30°31.77,
35.72. 3B, 50. 41.77, 60.
32°6 &, 81. 69.79. 77.30. 7
9.74.109.08゜127.28.127.72
.. 128.20.130.84.134.45゜139
.. 00.171.79 Synthesis of compound (P)>
Unsaturated ethyl carboxylate (B) 65m(J (0,
16m not), methanol 5Uil, water 1.2
5d and CuSO4・5H20186mg (0,75m
mof> was stirred and refluxed for 13 hours. After the reaction was completed, ethyl ether was added and the mixture was filtered through Celite-545. The filtrate was washed with saturated brine and dried over anhydrous magnesium balate. After distilling off the solvent under reduced pressure, silica gel column chromatography (ethyl acetate:hexane = 1:5 (container)
) is purified by the following chemical formula (33. 3'S,
35.5 mg of γ-lactone derivative (P) of 43> form was obtained (yield 69%).

(但し、3nはベンジル基を表わす) ’HNMR(CD(1’3 > δ:0.86    (3H,br  t、 J= 7
.2!lz。
(However, 3n represents a benzyl group) 'HNMR (CD(1'3 > δ: 0.86 (3H, br t, J = 7
.. 2! lz.

Ct−h) 1.0 〜1.8   (81−1,m、  CH2)
3.72〜3.9  (5H,m、CH2、CH)4.
4〜4.7  (IH,m、CH)4.36     
   (1H,d、  J=11.7Hz。
Ct-h) 1.0 ~ 1.8 (81-1, m, CH2)
3.72-3.9 (5H, m, CH2, CH)4.
4-4.7 (IH, m, CH) 4.36
(1H, d, J=11.7Hz.

CH2) 4.51     (IH,d、 J=41.7Hz。CH2) 4.51 (IH, d, J = 41.7Hz.

CH2) 5.55    (IH,dd、 J= 6.7Hz。CH2) 5.55 (IH, dd, J = 6.7Hz.

15.4Hz、 =CH) 5.68    (1H,dd、 J= 7.7tに1
5.4NZ、 =CH) 7.29     (5H,S、 Cs Hs )13
CNMR(CDC13) δ:  14.00. 22.57. 24.98. 
31.69. 34.94゜41.02. 62.27
. 70.42. 79.50. 82.60゜127
.52.127.62.128.23.135.62.
138.63゜176.48 (発明の効果) 本発明は、プロスタグランジン合成のための鍵中間体と
なる光学活性γ−ラクトン誘導体の製法であり、水沫を
用いることにより該誘導体を比較的簡便に、しかも効率
よく製造することができる。
15.4Hz, =CH) 5.68 (1H, dd, J= 1 in 7.7t
5.4NZ, =CH) 7.29 (5H,S, Cs Hs)13
CNMR (CDC13) δ: 14.00. 22.57. 24.98.
31.69. 34.94°41.02. 62.27
.. 70.42. 79.50. 82.60°127
.. 52.127.62.128.23.135.62.
138.63゜176.48 (Effects of the Invention) The present invention is a method for producing an optically active γ-lactone derivative, which is a key intermediate for prostaglandin synthesis. Moreover, it can be manufactured efficiently.

Claims (1)

【特許請求の範囲】 (1)下記一般式(B) ▲数式、化学式、表等があります▼(B) (上記一般式(B)において、R^1はアルコキシ基を
有していてもよいアルキル基、シクロアルキル基及び芳
香環もしくはアルキル基にヘテロ原子を有するアラルキ
ル基から選ばれた炭素数1〜12の基、R^2は水素原
子又はアシル基、シリル基、アラルキル基及びアルキル
オキシアルキル基から選ばれた容易に脱離可能な保護基
、R^4は炭素数1〜5の低級アルキル基を表わし、*
の符号は不斉炭素原子を表わす) で表わされる光学活性化合物を酸触媒の存在下で分子内
閉環させることを特徴とする下記一般式(P)で表わさ
れる光学活性γ−ラクトン誘導体の製法。 ▲数式、化学式、表等があります▼ 上記一般式(P)において、R^1、R^2及び*の符
号は一般式(B)のR^1、R^2及び*の符号と同じ
意味を表わす。 (2)一般式(P)のR^1が炭素数4〜10のアルキ
ル基である請求項1記載の製法。(3)アルキル基がペ
ンチル基である請求項2記載の製法。 (4)一般式(P)のR^2がアラルキル基である請求
項1〜3いずれかに記載の製法。(5)アラルキル基が
ベンジル基である請求項4記載の製法。 (6)一般式(P)の化合物が光学活性(3S、3′S
、4S)体である請求項1〜5いずれかに記載の製法。
[Claims] (1) The following general formula (B) ▲There are mathematical formulas, chemical formulas, tables, etc.▼(B) (In the above general formula (B), R^1 may have an alkoxy group A group having 1 to 12 carbon atoms selected from an alkyl group, a cycloalkyl group, and an aralkyl group having a heteroatom in an aromatic ring or an alkyl group, R^2 is a hydrogen atom or an acyl group, a silyl group, an aralkyl group, and an alkyloxyalkyl group. R^4 represents a lower alkyl group having 1 to 5 carbon atoms, and *
A method for producing an optically active γ-lactone derivative represented by the following general formula (P), which comprises intramolecularly closing an optically active compound represented by (the symbol represents an asymmetric carbon atom) in the presence of an acid catalyst. ▲There are mathematical formulas, chemical formulas, tables, etc.▼ In the above general formula (P), the signs R^1, R^2, and * have the same meaning as the signs R^1, R^2, and * in general formula (B). represents. (2) The method according to claim 1, wherein R^1 in the general formula (P) is an alkyl group having 4 to 10 carbon atoms. (3) The method according to claim 2, wherein the alkyl group is a pentyl group. (4) The method according to any one of claims 1 to 3, wherein R^2 in general formula (P) is an aralkyl group. (5) The method according to claim 4, wherein the aralkyl group is a benzyl group. (6) The compound of general formula (P) has optical activity (3S, 3'S
, 4S) is the production method according to any one of claims 1 to 5.
JP1140799A 1989-06-01 1989-06-01 Process for producing optically active γ-lactone derivative Expired - Lifetime JPH0631201B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1140799A JPH0631201B2 (en) 1989-06-01 1989-06-01 Process for producing optically active γ-lactone derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1140799A JPH0631201B2 (en) 1989-06-01 1989-06-01 Process for producing optically active γ-lactone derivative

Publications (2)

Publication Number Publication Date
JPH035470A true JPH035470A (en) 1991-01-11
JPH0631201B2 JPH0631201B2 (en) 1994-04-27

Family

ID=15277014

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1140799A Expired - Lifetime JPH0631201B2 (en) 1989-06-01 1989-06-01 Process for producing optically active γ-lactone derivative

Country Status (1)

Country Link
JP (1) JPH0631201B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5108943A (en) * 1991-01-02 1992-04-28 Micron Technology, Inc. Mushroom double stacked capacitor
US5260458A (en) * 1991-09-26 1993-11-09 Ortho Pharmaceutical Corporation 2-oxo tetrahydrofuran compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5108943A (en) * 1991-01-02 1992-04-28 Micron Technology, Inc. Mushroom double stacked capacitor
US5260458A (en) * 1991-09-26 1993-11-09 Ortho Pharmaceutical Corporation 2-oxo tetrahydrofuran compounds

Also Published As

Publication number Publication date
JPH0631201B2 (en) 1994-04-27

Similar Documents

Publication Publication Date Title
KR101986966B1 (en) How to make Vera Frost
US4703127A (en) Process for the preparation of prostanoids
JPH035470A (en) Production of optically active gamma-lactone derivative
EP0362816B1 (en) Cyclopenteneheptanoic acid derivatives and method of preparation thereof
JP2743797B2 (en) Preparation of optically active compounds
JP2785657B2 (en) Preparation of optically active compounds
JP2743798B2 (en) Preparation of optically active compounds
JP2785658B2 (en) Preparation of optically active compounds
JPH035472A (en) Optically active compound and its production
JPH035474A (en) Optically active compound and its production
EP1721894A1 (en) Process for the synthesis of prostaglandin derivatives
US5198588A (en) Optically active isoxazole derivatives and intermediates for preparation thereof
JP2654835B2 (en) Optically active 4-en-6-ol compounds, intermediates for their production and methods for their production
US4985571A (en) 6-membered lactones useful as intermediates for antilipemic mevalonic acid lactones
US5266703A (en) Optically active isoxazole derivatives
JP3356462B2 (en) Method for producing optically active compound using novel oxazolidone derivative
US5220074A (en) Optically active isoxazole derivatives and intermediates for preparation thereof as well as processes for producing the same
JP2731013B2 (en) 11-Epiisocarbacyclines and method for producing the same
US5210201A (en) Optically active isoxazole derivatives and intermediates for preparation thereof as well as processes for producing the same
JP2654834B2 (en) Optically active vinyl compound, intermediate for producing the same, and method for producing them
JPS5944336A (en) Novel preparation of 2-allylcyclopentanones
JPH06184051A (en) Optically active substituted cyclopropylalkanoic acid derivative and intermediate for its production
JPS6379882A (en) Production of prostacyclines
JPS6377853A (en) Isocarbacyclines and production thereof
JPH0559115B2 (en)